Andrew f Shorr

Andrew f Shorr's AcademicInfluence.com Rankings

Andrew f Shorr

Medical

#2097

World Rank

#2497

Historical Rank

Public Health

#303

World Rank

#315

Historical Rank

Epidemiology

#353

World Rank

#372

Historical Rank

medical Degrees

Andrew f Shorr

Philosophy

#6183

World Rank

#9180

Historical Rank

Logic

#3375

World Rank

#4522

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Andrew f Shorr's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is Andrew f Shorr Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andrew f Shorr's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. (2005) (971)
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. (2006) (750)
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. (2012) (502)
Critical care delivery in the United States: Distribution of services and compliance with Leapfrog recommendations* (2006) (429)
Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005 (2008) (393)
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant (2007) (314)
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database* (2006) (277)
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics (2005) (264)
Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure* (2005) (247)
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens (2011) (246)
Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study (2014) (235)
Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. (2004) (220)
Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysis (2005) (214)
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. (2008) (211)
Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs?* (2007) (208)
Red blood cell transfusion and ventilator-associated pneumonia: A potential link? (2004) (207)
Predicting mortality in patients with sarcoidosis awaiting lung transplantation. (2003) (200)
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. (2005) (193)
Etomidate is associated with mortality and adrenal insufficiency in sepsis: A meta-analysis* (2012) (178)
An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. (2009) (176)
Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay* (2010) (174)
Meta-Analysis: Outcomes in Patients with Suspected Pulmonary Embolism Managed with Computed Tomographic Pulmonary Angiography (2004) (171)
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. (2020) (170)
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts (2013) (168)
Epidemiology of staphylococcal resistance. (2007) (167)
Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. (2010) (167)
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit* (2009) (167)
Growth in adult prolonged acute mechanical ventilation: Implications for healthcare delivery* (2008) (163)
D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. (2002) (161)
Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia (2006) (159)
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients* (2008) (159)
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis* (2005) (155)
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients (2013) (154)
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis (2017) (154)
Prevention of venous thromboembolism in neurosurgery: a metaanalysis. (2008) (153)
Outcomes and safety of surgical lung biopsy for interstitial lung disease. (2005) (152)
Nosocomial bacterial meningitis. (2010) (148)
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. (2008) (139)
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States (2008) (138)
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome (2006) (137)
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. (2012) (136)
Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. (2007) (134)
Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia : potential economic implications. (2001) (134)
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. (2006) (133)
Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study (2008) (131)
Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005 (2008) (129)
Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME) (2011) (125)
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study (2010) (124)
Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections (2014) (123)
Outcomes for patients with sarcoidosis awaiting lung transplantation. (2002) (119)
Intensive care medicine research agenda on invasive fungal infection in critically ill patients (2017) (119)
Transfusion practice and blood stream infections in critically ill patients. (2005) (118)
A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections (2015) (117)
Endobronchial biopsy for sarcoidosis: a prospective study. (2001) (116)
Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy (2006) (113)
Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. (2009) (110)
Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. (2009) (108)
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia (2007) (107)
Implementing quality improvements in the intensive care unit: Ventilator bundle as an example (2009) (107)
Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. (2004) (107)
Secular Trends in Gram-Negative Resistance among Urinary Tract Infection Hospitalizations in the United States, 2000–2009 (2013) (106)
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. (2011) (103)
Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? (2010) (100)
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study (2007) (100)
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis (2011) (94)
Effect of standardized orders and provider education on head-of-bed positioning in mechanically ventilated patients (2003) (92)
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis (2016) (91)
Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus (2012) (90)
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. (2011) (90)
Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin* (2004) (90)
Validation of a novel risk score for severity of illness in acute exacerbations of COPD. (2011) (89)
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome (2011) (89)
Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning (2008) (87)
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) (2019) (82)
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. (2013) (80)
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. (2003) (79)
Sarcoidosis involving the musculoskeletal system. (2002) (78)
Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States (2019) (77)
New choices for central venous catheters: potential financial implications. (2003) (77)
Using the Number Needed to Treat to Assess Appropriate Antimicrobial Therapy as a Determinant of Outcome in Severe Sepsis and Septic Shock* (2014) (76)
Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease (2006) (75)
Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications* (2008) (74)
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia (2010) (74)
INCREASE IN CLOSTRIDIUM DIFFICILE-RELATED HOSPITALIZATIONS AMONG INFANTS IN THE UNITED STATES, 2000–2005 (2008) (74)
Venous thromboembolism in critically ill patients (2008) (74)
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study. (2016) (73)
Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. (2001) (73)
Clostridium difficile-associated disease and mortality among the elderly critically ill (2009) (71)
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. (2002) (71)
Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: Update using 2000–2008 data* (2012) (70)
Cost-Effectiveness Analysis of a Silver-Coated Endotracheal Tube to Reduce the Incidence of Ventilator-Associated Pneumonia (2009) (69)
Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005 (2008) (69)
Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. (2006) (69)
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia (2013) (67)
An update on cost-effectiveness analysis in critical care (2002) (66)
The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. (2012) (64)
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. (2008) (63)
Burden of early-onset candidemia: Analysis of culture-positive bloodstream infections from a large U.S. database* (2009) (62)
Mechanical ventilation in hematopoietic stem cell transplantation: can We effectively predict outcomes? (1999) (59)
Impediments to writing do-not-resuscitate orders. (1999) (58)
Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors (2009) (58)
Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis. (2008) (57)
Transfusion practice and nosocomial infection: assessing the evidence (2005) (56)
Aspergillus and endobronchial abnormalities in lung transplant recipients. (2000) (56)
Acute respiratory distress syndrome after kidney transplantation: Epidemiology, risk factors, and outcomes (2003) (56)
Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies. (2009) (55)
Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival (2014) (55)
The use of infliximab in cutaneous sarcoidosis. (2003) (53)
Sarcoidosis, race, and short-term outcomes following lung transplantation. (2004) (53)
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review (2010) (53)
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. (2010) (52)
Cholestatic jaundice associated with the use of metformin (2001) (52)
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. (2013) (52)
Fungal infections in the ICU. (2009) (52)
Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease. (2005) (51)
Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study (2008) (50)
The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. (2008) (49)
Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009–2013 (2018) (48)
Viruses are prevalent in non-ventilated hospital-acquired pneumonia (2016) (48)
Burden of sodium abnormalities in patients hospitalized for heart failure. (2011) (48)
Candidemia on presentation to the hospital: development and validation of a risk score (2009) (46)
Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data (2014) (46)
Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. (2010) (46)
Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. (2008) (46)
Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. (2009) (46)
The quick and the dead: the importance of rapid evaluation of infiltrates in the immunocompromised patient. (2002) (45)
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study. (2015) (45)
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study (2014) (44)
Antimicrobial stewardship: shepherding precious resources. (2009) (44)
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients. (2006) (44)
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation (2009) (43)
Health care-associated pneumonia: identification and initial management in the ED. (2008) (43)
Ventilator-Associated Pneumonia: Insights From Recent Clinical Trials (2005) (42)
New Choices for Central Venous Catheters (2003) (41)
Ethical assessment of industry-sponsored clinical trials: a case analysis. (2002) (39)
Clinical and Economic Outcomes for Patients with Health Care-Associated Staphylococcus aureus Pneumonia (2010) (38)
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia. (2005) (38)
Understanding cost-effectiveness. (2010) (36)
Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States (2016) (36)
Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications (2008) (36)
Application of a population-based severity scoring system to individual patients results in frequent misclassification (2005) (35)
FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials. (2014) (35)
Prolonged acute mechanical ventilation: implications for hospital benchmarking. (2009) (34)
Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. (2011) (34)
Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated) (2008) (34)
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. (2005) (34)
Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. (2008) (34)
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. (2010) (32)
Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. (2007) (31)
Practical utility of clinical prediction rules for suspected acute pulmonary embolism in a large academic institution. (2004) (30)
The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure: An Underappreciated Issue (2017) (30)
Endobronchial disease and racial differences in pulmonary sarcoidosis. (1997) (29)
Venous thromboembolic disease in the intensive care unit. (2010) (29)
Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis (2005) (29)
Guidelines and quality for community-acquired pneumonia: measures from the Joint Commission and the Centers for Medicare and Medicaid Services. (2009) (29)
Development and Validation of a Mortality Risk-Adjustment Model for Patients Hospitalized for Exacerbations of Chronic Obstructive Pulmonary Disease (2013) (28)
Endobronchial Disease and Racial Differences in Pulmonary Sarcoidosis (1997) (28)
Challenges and opportunities in the treatment of ventilator-associated pneumonia (2017) (26)
Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. (1997) (26)
Unnecessary use of placebo controls: the case of asthma clinical trials. (2002) (26)
Regulatory and educational initiatives fail to promote discussions regarding end-of-life care. (2000) (26)
Timing of antibiotic therapy in the ICU (2021) (26)
Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery. (2007) (26)
Intravenous fosfomycin for the treatment of hospitalized patients with serious infections (2017) (26)
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study. (2019) (26)
Circulating D dimer in patients with sarcoidosis. (2000) (26)
Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU (2011) (25)
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation (2007) (25)
Economics at the End of Life: Hospital and ICU Perspectives (2012) (25)
Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications (2001) (24)
30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study (2017) (24)
Cost-effectiveness of Linezolid for Treatment of Ventilator-Associated Pneumoni (2003) (24)
Osseous Sarcoidosis Clinical, Radiographic, and Therapeutic Observations (1998) (24)
Potential Limitations of Clinical Criteria for the Diagnosis of Idiopathic Pulmonary Fibrosis/Cryptogenic Fibrosing Alveolitis (2004) (24)
A Case Analysis (2002) (23)
Dollars and sense in the intensive care unit: the costs of ventilator-associated pneumonia. (2003) (23)
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (2014) (22)
Diagnostics and epidemiology in ventilator-associated pneumonia (2011) (22)
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. (2015) (22)
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens. (2017) (21)
Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients* (2012) (21)
Quinolones for treatment of nosocomial pneumonia: a meta-analysis. (2005) (21)
Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated) (2010) (21)
Epidemiology of healthcare-associated pneumonia (HCAP). (2009) (21)
Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei. (2011) (20)
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections (2012) (20)
Assessment of Time to Clinical Response, a Proxy for Discharge Readiness, among Hospitalized Patients with Community-Acquired Pneumonia Who Received either Ceftaroline Fosamil or Ceftriaxone in Two Phase III FOCUS Trials (2014) (20)
Healthcare-associated pneumonia: the state of evidence to date. (2011) (20)
Nosocomial Infection. (2021) (20)
Predicting the need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: comparing the CURB-65 and BAP-65 scores. (2012) (19)
Preventing pneumonia: the role for pneumococcal and influenza vaccines. (2005) (19)
The protein C pathway: implications for the design of the RESPOND study (2007) (19)
Ventilator-associated pneumonia: insights from recent clinical trials. (2005) (19)
Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. (2012) (18)
Economic aspects of preventing health care-associated infections in the intensive care unit. (2012) (18)
Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: A retrospective cohort study. (2015) (18)
Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trials. (2007) (18)
Burden of Deep Vein Thrombosis in the Outpatient Setting Following Major Orthopedic Surgery (2008) (18)
The role of telavancin in hospital-acquired pneumonia and ventilator-associated pneumonia. (2015) (18)
Interferon gamma-1b as Therapy for Idiopathic Pulmonary Fibrosis (2004) (17)
Determinants of outcome in patients with a clinical suspicion of ventilator-associated pneumonia. (2008) (17)
Update in ventilator-associated pneumonia (2006) (17)
Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study (2014) (16)
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018 (2020) (16)
Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study (2015) (16)
Management of idiopathic pulmonary haemosiderosis in pregnancy: Report of two cases (2003) (15)
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial (2016) (15)
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia. (2009) (15)
Recurrent Clostridium difficile infection among Medicare patients in nursing homes (2017) (15)
Preventing clostridium difficile infection in the intensive care unit. (2013) (15)
Accuracy of Previous Estimates for Adult Prolonged Acute Mechanical Ventilation Volume in 2020: Update Using 2000-2008 Data (2011) (15)
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials. (2013) (15)
Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials. (2019) (15)
Transfusion practice in the ICU: when will we apply the evidence? (2005) (15)
Bacteremia increases the risk of death among patients with soft-tissue infections. (2010) (15)
Characteristics, Hospital Course, and Outcomes of Patients Requiring Prolonged Acute Versus Short-Term Mechanical Ventilation in the United States, 2014–2018* (2020) (14)
Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study (2019) (14)
Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study (2013) (14)
The pharmacoeconomics of deep vein thrombosis treatment. (2007) (13)
Clostridium difficile Recurrence Is a Strong Predictor of 30-Day Rehospitalization Among Patients in Intensive Care (2014) (13)
Development and Validation of a Risk Score for Clostridium difficile Infection in Medicare Beneficiaries: A Population‐Based Cohort Study (2016) (13)
SEVERE PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS (2006) (13)
Depreotide scanning in sarcoidosis: a pilot study. (2004) (13)
Impact of Vancomycin Minimum Inhibitory Concentration on Mortality among Critically Ill Patients witn Methicillin-Resistant Staphylococcus aureus Bacteremia (2012) (13)
Comparing the pulmonary embolism severity index and the prognosis in pulmonary embolism scores as risk stratification tools. (2012) (13)
The rule of double effect. (1998) (12)
Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy. (2012) (12)
The yield of lumbar puncture to exclude nosocomial meningitis as aetiology for mental status changes in the medical intensive care unit. (2006) (11)
Intralobular bronchopulmonary sequestrations associated with bronchogenic cysts. (2005) (11)
Hospital readmission with Clostridium difficile infection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis (2018) (11)
Severe acute hypertension among inpatients admitted from the emergency department. (2012) (11)
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux (2006) (11)
Is the implementation of research findings in the critically ill hampered by the lack of universal definitions of illness? (2003) (10)
Do intensive care unit patients have intensive care unit physicians? Unfortunately not. (2006) (10)
Postdischarge Oral Versus Injectable Anticoagulation Following Major Orthopedic Surgery (2008) (10)
Inhaled antibiotics for the treatment of pneumonia (2019) (10)
Health care-associated candidemia--a distinct entity? (2010) (10)
Not everything that can be counted counts ... (2008) (10)
Development and validation of a bedside instrument to predict carbapenem resistance among gram-negative pathogens in complicated urinary tract infections (2018) (10)
Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis (2017) (9)
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial (2021) (9)
AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. (1992) (9)
Swine origin influenza A (H1N1) virus and ICU capacity in the US (2009) (9)
Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia. (2010) (9)
Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign. (2005) (9)
Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019 (2021) (9)
Making the wrong choice: Consequences for patients with infections due to methicillin-resistant Staphylococcus aureus. (2006) (8)
Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP) (2015) (8)
Red blood cell transfusion in the critically ill: when is it time to say enough? (2009) (8)
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world (2015) (8)
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study (2021) (8)
Cost-minimization analysis of two algorithms for diagnosing acute pulmonary embolism. (2004) (8)
Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumonia. (2014) (8)
Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation (2012) (8)
Non-infectious pulmonary disorders in HIV (2017) (7)
Vasopressin and cardiac performance. (2002) (7)
Appropriate Antibiotic Treatment in Severe Sepsis and Septic Shock: Timing Is Everything. (2015) (7)
Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013 (2019) (7)
Meningitis and Hepatitis Complicating Intravenous Immunoglobulin Therapy (1996) (7)
Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-No. (2021) (7)
GROWTH IN ADULT-PROLONGED ACUTE MECHANICAL VENTILATION: IMPLICATIONS FOR HEALTH-CARE DELIVERY (2007) (7)
Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018 (2022) (7)
Transfusion in critical care: where do we go from here? (2007) (6)
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board (2019) (6)
THE IMPACT OF PULMONARY HYPERTENSION ON SURVIVAL IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS LISTED FOR LUNG TRANSPLANT (2007) (6)
No longer the "expensive scare unit"? (2004) (6)
Resistance in the intensive care unit: whose problem is it and how can intensivists help? (2007) (6)
Antibiotics in the critically ill: the bug, drug, host triad. (2012) (6)
Quality pneumonia care: distinguishing community-acquired from health care-associated pneumonia. (2009) (6)
Who Is at Risk for Psychological Distress (2015) (6)
Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections—A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence Drug (2020) (5)
GROWTH IN THE INCIDENCE OF HOSPITALIZATIONS WITH RESISTANT INFECTIONS IN ELDERLY PEOPLE IN THE UNITED STATES: 2000 TO 2006 (2008) (5)
PZA Hypersensitivity-To the Editor (1996) (5)
Ineffectiveness of Routine Abdominal Radiography in Patients With Gastrointestinal Hemorrhage Admitted to an Intensive Care Unit (2005) (5)
Vapotherm: A Novel high-Flow Oxygen Delivery Syste (2003) (5)
Economic and outcomes aspects of venous thromboembolic disease. (2012) (5)
The seven deadly sins of ventilator-associated pneumonia. (2008) (5)
Prolonged mechanical ventilation: pushing the limits of magic in medicine? (2009) (5)
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014–2019 (2022) (5)
Role for risk-scoring tools in identifying resistant pathogens in pneumonia: reassessing the value of healthcare-associated pneumonia as a concept (2015) (5)
Nature (and the ICU) abhors a VACuum. (2012) (5)
Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors (2020) (5)
Economic and Utilization Burden of Hospital-Acquired Pneumonia (HAP): A Systematic Review and Meta-analysis (2010) (4)
Going Viral: Importance of Viral Pathogens in Nonventilated Hospital-Acquired Pneumonia. (2016) (4)
Augmented renal clearance: an augmented definition of appropriate antibiotic therapy?*. (2014) (4)
Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival (2014) (4)
Issues in antibiotic therapy for hospital-acquired and ventilator-associated pneumonia: emerging concepts to improve outcomes (2021) (4)
Deep vein thrombosis in the intensive care unit: underappreciated, understudied, and undertreated. (2005) (4)
Role for transbronchial biopsy in the diagnosis of usual interstitial pneumonia. (2007) (4)
718Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study (2014) (4)
Scyphozoa (2022) (4)
Depreotide Scanning in Sarcoidosis (2004) (4)
More, please. (2013) (4)
Outcomes Of Vancomycin Weight Based Dosing By Trough Concentrations For The Treatment Of Hospital Acquired Pneumonia Caused By Methicillin-Resistant Staphylococcus Aureus (2011) (3)
THE CHANGING EPIDEMIOLOGY OF NON-NOSOCOMIAL STAPHYLOCOCCUS AUREUS PNEUMONIA (2008) (3)
The Effect of Interferon Alone vs Interferon Plus Corticosteroids in Patients With Idiopathic Pulmonary Fibrosi (2003) (3)
Opinion-Based Recommendations: Beware the Tyranny of Experts (2021) (3)
OBSERVED INCIDENCE OF VENOUS THROMBOEMBOLISM IN SOLDIERS FROM OPERATION IRAQI FREEDOM AND OPERATION ENDURING FREEDOM ADMITTED TO A STATESIDE INTENSIVE CARE UNIT (2005) (3)
Clinical trials in the critically ill: practical and ethical challenges: comment on "Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support". (2011) (3)
There is no "cap" on the importance of community-acquired pneumonia in the ICU. (2008) (3)
Blood transfusion and nosocomial infection: another brick in the wall. (2006) (3)
Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019 (2022) (3)
TELAVANCIN: A NOVEL AGENT FOR VENTILATOR-ASSOCIATED PNEUMONIA DUE TO STAPHYLOCOCCUS AUREUS (2008) (3)
Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey (2014) (3)
Going Viral—RSV as the Neglected Adult Respiratory Virus (2022) (3)
The evolving burden of viruses in pneumonia (2019) (3)
Meropenem-Vaborbactam vs. Piperacillin-Tazobactam in TANGO I (a Phase 3 Randomized, Double-blind Trial): Outcomes by Baseline MIC in Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis (2017) (3)
Update on Clostridium difficile Hospitalizations in the US Through 2008: The Epidemic Continues (2011) (2)
Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance. (2021) (2)
PZA hypersensitivity. (1996) (2)
INCIDENCE AND RELATED OUTCOMES OF PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS (2005) (2)
Mitigating VTE in soldiers from Operation Iraqi Freedom and Operation Enduring Freedom. (2014) (2)
Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018 (2022) (2)
Fulminant Hepatic Failure due to Herpes Simplex Virus in a Previously Healthy Woman: Case Report and Review of the Literature (2006) (2)
The Answer for Inhaled Antibiotics in Pneumonia Is Still Blowing in the Wind. (2017) (2)
Black clouds and black boxes: comment on "Long-acting β2-agonist step-off in patients with controlled asthma". (2012) (2)
Mortality from time of listing for transplantation as an indicator of candidate outcomes. (2004) (2)
Linezolid Vs. Vancomycin For Ventilator-Associated Pneumonia Caused By Methicillin-Resistant Staphylococcus Aureus (2011) (2)
Epidemiology of Community-Acquired and Health Care-Associated Staphylococcus aureus Pneumonia (2010) (2)
The pulmonary arteries, idiopathic pulmonary fibrosis, and lung transplantation: deciphering the connection. (2011) (2)
Update on epidemiology and appropriate treatment of life-threatening gram-negative infections. (2018) (2)
Free cortisol and critically ill patients. (2004) (2)
Validation Of A Clinical Score For Assessing The Risk Of Resistant Pathogens In Pneumonia Presenting To The Emergency Department (2012) (2)
The 4T and Chong Scores Correlate With Outcomes for Heparin-Induced Thrombocytopenia (2010) (2)
Salmeterol and inhaled corticosteroids in patients with persistent asthma. (2001) (2)
Chest Radiographs Can Minimize the Use of Computed Tomography of the Chest When Combined With Screening Scores for Pulmonary Embolism Evaluation (2012) (2)
THE EFFECT OF HEAD OF BED POSITION ON ASPIRATION OF GASTRIC CONTENTS IN PATIENTS RECEIVING MECHANICAL VENTILATION: A COMPARISON OF 30 VS 45 DEGREES (2006) (2)
Quality indicators: not everything that can be counted counts*. (2014) (2)
Adequacy Of Empiric Antibiotic Therapy For Ventilator Associated Pneumonia: Still An Important Determinant Of Outcome (2010) (2)
Transfusion: A Risk Factor for Nosocomial Bacteremia in the Intensive Care Unit (2004) (2)
Emergency department patients with acute severe hypertension: a comparison of those admitted versus discharged in studying the treatment of acute hypertension registry. (2014) (2)
Anticoagulants for acute ischemic stroke. (2008) (2)
Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges (2021) (2)
Continuous infusion of beta-lactams: a blissful option for the intensive care unit. (2016) (1)
PCV12 FONDAPARINUX IS ECONOMICALLY NON-INFERIOR TO ENOXAPARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM (2009) (1)
Reply to Moine and Bédos (2005) (1)
The swan song of the pulmonary artery catheter. (2013) (1)
Lung Cancer Screening Contumacy vs Mendacity (1)
HEALTHCARE-ASSOCIATED PNEUMONIA: A VALUABLE CONCEPT AT PREDICTING RESISTANT INFECTION? (2008) (1)
Frequency of Contrast Induced Nephropathy in Patients Who Undergo Computed Tomography Pulmonary Angiography for Pulmonary Embolism (2014) (1)
Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey (2012) (1)
663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Clinical Trials (2019) (1)
' s response to reviews Title : Hospital days , hospitalization costs , and inpatient mortality among patients with mucormycosis : a retrospective analysis of U . S . hospital discharge data (1)
Recurrent Clostridium dif fi cile infection among Medicare patients in nursing homes A population-based cohort study (2017) (1)
30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study (2017) (1)
FORM OF POST-DISCHARGE ANTICOAGULATION FOLLOWING MAJOR ORTHOPEDIC SURGERY: IMPACT ON OUTCOMES (2007) (1)
Bang for Your Buck: Could Medicare's Hospital Value-Based Purchasing Program Rein in Health-Care Spending in Pneumonia? (2020) (1)
Epidemiology and Statistics for the Boards (2012) (1)
Ventriculitis: Infection or Inflammation (2021) (1)
Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP (2022) (1)
Impact of Inappropriate Empiric Treatment of Acinetobacter Baumannii Pneumonia and Sepsis on Hospital Mortality (2016) (1)
PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: EPIDEMIOLOGY AND CLINICAL CORRELATES (2005) (1)
The United States needs a health system like other countries. (1994) (1)
Admitting What We Do Not Know About Pneumonia Readmissions. (2015) (1)
The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (2012) (1)
Sepsis and Septic Shock: Evolving Evidence, Evolving Paradigms. (2022) (1)
348: MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA AMONG HOSPITALIZED PATIENTS WITH PNEUMONIA, US 2000-2009 (2012) (1)
A 36-year-old Haitian man with coma, acute kidney injury, lactic acidosis, and respiratory failure. (2012) (1)
INCIDENCE OF VENOUS THROMBOEMBOLISM IN SEVERE SEPSIS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) WITH OR WITHOUT PROPHYLACTIC-DOSE HEPARIN (2006) (1)
Impact of Roflumilast on Exacerbations Among Patients With Chronic Obstructive Pulmonary Disease (COPD) in the Real World (2013) (1)
Moral Connections? The Relationship between Abortion and Fetal Tissue Research (1994) (1)
698: CHARACTERISTICS OF CULTURE POSITIVE AND CULTURE NEGATIVE SEVERE SEPSIS PATIENTS ADMITTED FROM THE EMERGENCY DEPARTMENT (2012) (1)
PULMONARY EMBOLISM SEVERITY INDEX CORRELATES WITH TROPONIN IN PULMONARY EMBOLISM (2009) (1)
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges (2022) (1)
HEPARIN-PLATELET FACTOR 4 (HPF4) ANTIBODIES IN PATIENTS WITHOUT HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): IMPLICATIONS FOR ICU RESOURCE UTILIZATION FOLLOWING CARDIOPULMONARY BYPASS (CPB).: 102-M (2005) (1)
EFFICACY AND SAFETY OF LEFAMULIN VS MOXIFLOXACIN FOR ATYPICAL RESPIRATORY PATHOGENS IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: POOLED RESULTS FROM THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS (2019) (1)
A Phase II Randomized , Double-blind , Multicenter Study to Evaluate Ef fi cacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Con fi rmed to be Due to Gram-positive Pathogens (2017) (1)
Predictors Of Clinical Failure And Mortality Among Patients With Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Acquired Pneumonia (2011) (1)
Moral Connections:: The Relationship between Abortion and Fetal Tissue Research* (1994) (1)
Are Hospitals Following Guidelines for VTE Prevention? the Veneous Thromoembolism Study to Assess the Rate of Thromboprophylaxis (2008) (1)
ANEMIA AND TRANSFUSIONS AMONG CRITICALLY ILL PATIENTS ON PROLONGED MECHANICAL VENTILATION (2006) (1)
The importance of viruses in ventilator-associated pneumonia. (2022) (0)
Impact of Vancomycin MICs on Critically Ill Patients With MRSA Bacteremia (2011) (0)
Molecular Diagnostics Require a Bayesian Approac (2012) (0)
Prevalence and Outcomes of Clostridium difficile Infection among Patients Hospitalized with Sepsis in the US. (2009) (0)
SurvivalClinical Response and 28-Day Telavancin for Hospital-Acquired (2014) (0)
Outcomes in the ICU. (2010) (0)
RED BLOOD CELL TRANSFUSIONS AND THE RISK OF ICU-ONSET ACUTE RESPIRATORY DISTRESS SYNDROME.: 462 (2006) (0)
IMPACT OF TRANSFUSION ON OUTCOMES IN CRITICALLY ILL PATIENTS REQUIRING PROLONGED MECHANICAL VENTILATION.: 491 (2006) (0)
A Risk Score For Identifying Patients With Methicillin-Resistant Staphylococcus Aureus Pneumonia Presenting To The Hospital (2011) (0)
Nitric Oxide and Impaired Oxygenation before and after Liver Transplantation (1999) (0)
1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018 (2019) (0)
616: OUTCOMES IN PATIENTS WITH AUGMENTED RENAL CLEARANCE TREATED WITH CEFTOLOZANE-TAZOBACTAM IN ASPECT-NP (2020) (0)
354: THE IMPACT OF A UNIQUE AIRWAY CLEARANCE SYSTEM ON AIRWAY MECHANICS IN VENTILATED PATIENTS (2013) (0)
Heeding the Prophetic Call: New Insights Into Nosocomial Pneumonia. (2020) (0)
Distance-Saturation Product as a Marker of Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis (2004) (0)
Ventilator-associated pneumonia: we cannot wish it away*. (2014) (0)
Dollars and sense in sepsis. (2011) (0)
Recurrent Clostridium difficile infection among nursing home Medicare patients: A population-based cohort study (2016) (0)
IMPACT OF INITIAL ANTICOAGULANT CHOICE ON RECURRENT VENOUS THROMBOEMBOLISM IN OUTPATIENT SETTING (2009) (0)
SEVERE NON-NOSOCOMIAL PNEUMONIA IN THE ICU: LETTING THE CAP OUT OF THE BAG (2008) (0)
HEALTHCARE-ASSOCIATED PNEUMONIA: THE STATE OF EVIDENCE TO DATE?A QUALITATIVE REVIEW (2009) (0)
PRS3 AVALIDATION STUDY ON USING MORTALITY RISK STRATIFICATION TOOL TO STRATIFY ECONOMIC RISK IN PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (AECOPD) (2008) (0)
PSYCHOTHERAPY FOR DEPRESSION IN DIABETES. AUTHORS' REPLY (1999) (0)
60 Can We Reduce the Use of Computed Tomography Pulmonary Angiography in Young Female Patients Being Evaluated for Pulmonary Embolism (2012) (0)
INTERMEDIATE-TERM OUTCOMES FOLLOWING TRANSPLANT FOR SARCOIDOSIS RELATIVE TO SURVIVAL AFTER TRANSPLANT FOR IDIOPATHIC PULMONARY FIBROSIS (2005) (0)
Author's response to reviews Title: Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study Authors: (2008) (0)
Author ' s response to reviews Title : Imipenem resistance of Pseudomonas in pneumonia : A systematic literature review (0)
Emerging Modalities to Combat Resistant Gram-Negative Pathogens In Critically Ill Patients: Part 1: Changes in Gram-Negative Resistance Over Time (2008) (0)
Bacteremia in Staphylococcus aureus Pneumonia: Outcomes and Epidemiology in the ICU (2010) (0)
General Management of Suspected Pneumonia in the Solid Organ Transplant Patient (2009) (0)
Doripenem for Pseudomonas aeruginosa : Insights from Clinical Trials (2008) (0)
NOSOCOMIAL BACTEREMIA AND SEPSIS: EPIDEMIOLOGY, OUTCOMES, AND COST: 545 (2004) (0)
Population health issue in critical care: expanding our focus beyond the intensive care unit. (2012) (0)
' s response to reviews Title : Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections (2012) (0)
Acute Decompensated Heart Failure: Examining Those With Brief Hospitalizations (2023) (0)
732: AZITHROMYCIN AND PNEUMONIA (2012) (0)
Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: A (2013) (0)
Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis (2023) (0)
Reply to van de Peppel and de Boer. (2018) (0)
The Effect of Etomidate on Adrenal Insufficiency and Mortality: A Meta-analysis (2011) (0)
Time Trends in the Burden of Hospitalizations with Invasive Aspergillosis in the United States, 2004–2013 (2017) (0)
793: Impact of Fluconazole Prophylaxis on Fungal Microbiology in Intra-abdominal Surgery Patients (2013) (0)
Inpatient Thromboprophylaxis with Enoxaparin and Fondaparinux in Elderly Orthopedic Surgery Patients. (2009) (0)
Mortality of Elderly Patients With Immunosuppression and Severe Sepsis (2011) (0)
300: HOSPITALIZATIONS WITH ACINETOBACTER BAUMANNII PNEUMONIA AND SEPSIS IN THE US (2015) (0)
PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING STROKE: INSIGHTS FROM A METAANALYSIS (2007) (0)
RATES AND OUTCOMES OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE (CDAD) AMONG PATIENTS ON PROLONGED ACUTE MECHANICAL VENTILATION (PAMV) (2008) (0)
A minority of patients on mechanical ventilation consume disproportionate resources: A retrospective cohort study. (2020) (0)
The clot thickens. (2009) (0)
Response to: ‘letter to the editor: “Challenges and opportunities in the treatment of ventilator-associated pneumonia”’ (2017) (0)
Azithromycin and Mortality in Streptococcus pneumoniae Pneumonia (2012) (0)
INAPPROPRIATE ANTIFUNGAL THERAPY FOR CANDIDEMIA AND HOSPITAL RESOURCE UTILIZATION (2009) (0)
Inhibitory Concentration on Mortality study Overview and Subjects among Critically ill Fatients witn Methicillin-Resistant Staphylococcus aureus Bacteremia (2014) (0)
Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US (2023) (0)
articleInappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization : a retrospective cohort study (2010) (0)
409: DIAGNOSIS, DISPOSITION, AND DEATHS OF PATIENTS EVALUATED FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT. (2012) (0)
Trends in AIDS epidemic. (1993) (0)
Venous thromboembolism D-dimer and the intensive care unit. (2000) (0)
Novel BAP-65 Score Outperforms CURB-65 Score For Predicting Outcomes In Acute Exacerbations Of Chronic Obstructive Disease (2010) (0)
717. Lefamulin (LEF) vs. Moxifloxacin (MOX) in Patients With Community-Acquired Bacterial Pneumonia (CABP) at Risk for Poor Efficacy or Safety Outcomes: Pooled Subgroup Analyses From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Noninferiority Clinical Trials (2019) (0)
ECONOMIC IMPLICATIONS OF SEPSIS PROTOCOL: CAN WE IMPROVE OUTCOMES AND SAVE COSTS?: 73 (2006) (0)
PIN61 Bacteriology and Inappropriate Empiric Therapy in Mixed Complicated Skin and Skin Structure Infections (2012) (0)
DESCRIPTIVE EVALUATION OF EARLY- VS. LATE-ONSET ACUTE RESPIRATORY DISTRESS SYNDROME.: 516 (2006) (0)
Novelty and nuance in the intensive care unit: new options to combat multidrug resistant pneumonia. (2020) (0)
META-ANALYSIS: THREE TIMES DAILY SUBCUTANEOUS HEPARIN IS NOT SUPERIOR TO TWICE DAILY THERAPY IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN MODERATE TO HIGH RISK MEDICAL INPATIENTS (2005) (0)
Costs for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia (2007) (0)
The authors reply. (2013) (0)
Endobronchial Sarcoidosis and (2015) (0)
1658C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients (2014) (0)
Predictors Of Failure Of Non-Invasive Ventilation For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease (2012) (0)
Early Markers of the Need for Prolonged Acute Vs. Short-Term Mechanical Ventilation in the US, 2014-2018: Results from a Multicenter Cohort Study (2020) (0)
INABILITY TO PREDICT ETIOLOGY IN FUNGEMIA IN THE ICU: IMPLICATIONS OF THE PREVALENCE OF NON-ALBICANS (NA) CANDIDEMIA.: 179-T (2005) (0)
Prevalence Significantly Affects the Diagnostic Tests Used for Heparin-Induced Thrombocytopenia (2012) (0)
High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia (2008) (0)
VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial, (2011) (0)
Revising the HCAP Criteria: Is There Still a Role for ESRD/Hemodialysis? (2011) (0)
Fungal Infections in Pulmonary Medicine (2012) (0)
The authors reply [19] (2006) (0)
READMISSION RATES FOR RECURRENT VENOUS THROMBOEMBOLISM OR MAJOR BLEEDING IN PATIENTS ADMINISTERED ACUTE INPATIENT TREATMENT WITH FONDAPARINUX OR ENOXAPARIN (2009) (0)
Kollef From Recent Clinical Trials Ventilator-Associated Pneumonia : Insights 3 S (2005) (0)
Prognostic Scoring Tools for Acute Pulmonary Embolism: The Pulmonary Embolism Severity Index vs Prognosis in Pulmonary Embolism (2010) (0)
REFINING THE CONCEPT OF HEALTHCARE-ASSOCIATED PNEUMONIA: PREDICTION RULES FOR RESISTANT PATHOGENS IN SEVERE PNEUMONIA IN THE EMERGENCY DEPARTMENT (2009) (0)
Neurosurgery: A Metaanalysis Prevention of Venous Thromboembolism in (2008) (0)
PARETO PRINCIPLE IN THE ICU: THE CASE OF MECHANICAL VENTILATION (2020) (0)
Epidemiology and Outcomes of Hospitalizations with Invasive Aspergillosis in the United States, 2010–2013 (2017) (0)
Carbapenem-Resistance in Enterobacteriaceae Among Hospitalized Patients With Urinary Tract Infection, Pneumonia and Sepsis Increases the Risk of Receiving Inappropriate Empiric Treatment (2016) (0)
CPR-Not-Indicated and Futility (1996) (0)
National Leadership Coalition's Plan for Health Care Reform. (1993) (0)
2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study (2019) (0)
PIN51 HOSPITAL LENGTH OF STAY AND COSTS ASSOCIATED WITH INAPPROPRIATE TREATMENT OF CANDIDEMIA IN THE ICU (2009) (0)
The Effect of Dedicated Critical Care Ultrasound Training Across Multiple Centers in Fellow Knowledge in Point-of-Care Ultrasonography (2019) (0)
484: Prolonged Acute Versus Short-Term Mechanical Ventilation in Surgical Patients in the US, 2014–2018 (2020) (0)
Treating Air Hunger at End-of-Life (2004) (0)
Transfusion: A Risk Factor for Ventilator-Associated Pneumonia (2003) (0)
Prospective Observation of Air Hunger in Severely Ill Patients (2004) (0)
Acute Eosinophilic Pneumonia in Soldiers Deployed as Part of Operations Iraqi Freedom & Enduring Freedom (2004) (0)
HEALTHCARE-ASSOCIATED BACTEREMIA: A DISTINCT CONCEPT (2009) (0)
Salicylate overdose (1986) (0)
PULMONARY EMBOLISM SEVERITY INDEX (PESI) AS A PREDICTOR OF 90 DAY MORTALITY (2009) (0)
1460: EPIDEMIOLOGY AND OUTCOMES OF SEPSIS-ASSOCIATED COAGULOPATHY IN SEVERE SEPSIS AND SEPTIC SHOCK (2016) (0)
Update in ventilator-associated pneumonia. [Review] [38 refs] (2006) (0)
Bacteremia in the setting of MRSA hospital-onset pneumonia is associated with a dramatic increase in the hospital length of stay: a retrospective cohort study (2015) (0)
THE YIELD OF LUMBAR PUNCTURE FOR NOSOCOMIAL MENINGITIS IN THE MEDICAL INTENSIVE CARE UNIT: 350 (2002) (0)
SAFETY AND TOLERABILITY OF LEFAMULIN VS MOXIFLOXACIN IN ADULTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: RESULTS OF THE LEFAMULIN EVALUATION AGAINST PNEUMONIA (LEAP) 1 AND LEAP 2 DOUBLE-BLIND NONINFERIORITY PHASE-3 CLINICAL TRIALS (2019) (0)
344: CONTRAST-INDUCED NEPHROPATHY POST CT PULMONARY ANGIOGRAPHY ARE RISKS HIGHER IN THE CRITICALLY ILL? (2013) (0)
UNDERSTANDING THE HEALTH CARE-ASSOCIATED PNEUMONIA (HCAP) DEFINITION (2008) (0)
Microbiologic Failure Despite Clinical Cure in Pneumonia: Cum Hoc and Post Hoc Ergo Propter Hoc. (2019) (0)
HEALTHCARE ASSOCIATED PNEUMONIA, INITIAL CHOICE OF ANTIMICROBIAL THERAPY AND OUTCOMES AMONG PATIENTS HOSPITALIZED WITH PNEUMONIA IN THE PRESENCE AND ABSENCE OF RESPIRATORY FAILURE (2008) (0)
Does Stress Ulcer Prophylaxis Explain the Association Between Clostridium difficile-Associated Disease and Mechanical Ventilation?: Response (2010) (0)
Research articleInappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization : a retrospective cohort study (2016) (0)
Ventilator-Associated Pneumonia Reduced — Mortality Untouched (2013) (0)
What does it mean: Appropriate therapy for methicillin-resistant Staphylococcus aureus? (2007) (0)
Agreement between patient-reported and chart documented outcomes: Case study in COPD (2013) (0)
1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019 (2021) (0)
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019 (2022) (0)
The Pulmonary Embolism Severity Index (PESI) Predicts The Presence Of Right Ventricular (RV) Strain (2010) (0)
Stragetic options for the management of severe gram-negative infections (2016) (0)
Pulmonary Hypertension in Sarcoidosis: Identifying Potential Risk Factors (2004) (0)
B-Type Natriuretic Peptide And Liberation From Mechanical Ventilation: A Meta-Analysis (2012) (0)
In reply (2011) (0)
Diagnostic Strategies , and Outcomes Immunocompromised Patient : Etiologies , Pulmonary Infiltrates in the Non-HIV-Infected (2003) (0)
Causes of Early Death Following Lung Transplantation in Sarcoidosis (2003) (0)
Safety of Surgical Lung Biopsy in Suspected Idiopathic Pulmonary Fibrosi (2003) (0)
775: EPIDEMIOLOGY OF HEPARIN INDUCED THROMBOCYTOPENIA IN THE INTENSIVE CARE UNIT (2012) (0)
INTEROBSERVER VARIABILITY OF THE PULMONARY EMBOLISM SEVERITY INDEX (PESI) (2008) (0)
792: IMPACT OF NEW BREAK POINTS FOR PIPERACILLIN/TAZOBACTAM FOR PSEUDOMONAS AERUGINOSA ON POTENTIAL RATES OF INITIALLY APPROPRIATE THERAPY IN BACTEREMIA (2012) (0)
Levofloxacin 750mg daily for 5 days for Community Acquired Pneumonia: Outcomes in the Elderly (2004) (0)
THE WANING PREVALENCE AND IMPACT OF INAPPROPRIATE ANTIBIOTIC THERAPY IN SEVERE NON-NOSOCOMIAL PNEUMONIA (2009) (0)
Low Molecular Weight Heparin Versus Fondaparinux for Thromboprophylaxis in Abdominal or Major Orthopedic Surgery Patients. (2009) (0)
Impact of Inappropriate Empiric Treatment of Enterobacteriaceae Urinary Tract Infection, Pneumonia and Sepsis on Hospital Outcomes (2016) (0)
???Nail??? That Foreign Body Aspiration Diagnosis Before Thoracotomy (2005) (0)
Reply to Edelstein and Humphries, “Improbable Results of Urine Isolate Antimicrobial Susceptibility Testing” (2020) (0)
Impediments to the use of do-not-resuscitate orders (1996) (0)
Comparing Triage Decisions For Critically Ill Patients: Residents Vs Attendings (2010) (0)
COST-SAVING ASSOCIATED WITH EARLY FAVORABLE MANAGEMENT OF SERUM SODIUM FOR PATIENTS ADMITTED WITH PNEUMONIA AND HYPONATREMIA (2008) (0)
Abstract 4353: Economic Burden of Prolonged Hyponatremia in Patients Admitted with Congestive Hear Failure (CHF) and Hyponatremia (2008) (0)
Quinolones For Nosocomial Pneumonia: A Meta-analysis (2004) (0)
Economic Outcomes Among Patients Requiring Prolonged Acute vs. Short-Term Mechanical Ventilation in the US, 2014-2018: Results from a Multicenter Cohort Study (2020) (0)
Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis: A Cost-effectiveness Analysis (2012) (0)
Surviving sepsis: a time for "don't just do something, stand there" philosophy? (2012) (0)
Imipenem Resistance of Pseudomonas in Nosocomial Pneumonia: A Systematic Literature Review. (2009) (0)
Orthotopic Lung Transplant for Sarcoidosis (2003) (0)
The Burden of Methicillin Resistant Staphylococcus aureus in Ventilator-Associated Pneumonia (2004) (0)
VENOUS THROMBOEMBOLISM FOLLOWING HIP FRACTURE SURGERY: OUTCOMES AS A FUNCTION OF PHARMACOLOGIC PROPHYLAXIS (2006) (0)
Methicillin-Resistant Staphylococcus aureus and the Epidemiology of Health-care-Associated Pneumonia (2010) (0)
Table of Contents (2020) (0)
Abstract 16714: Real-World Cost of All-Cause Hospitalizations Over a 12-Month Period After Acute Venous Thromboembolism (2014) (0)
1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018 (2019) (0)
Retrospective Assessment of Time to Being Dischargeable From Hospital for Community Acquired Pneumonia (CAP) Using Data From the FOCUS Trials (2013) (0)
BACTEREMIA MODIFIES THE EFFECT OF INITIAL ANTIBIOTIC TREATMENT ON HOSPITAL MORTALITY DIFFERENTIALLY IN CAP AND HCAP (2008) (0)
The Incidence and Outcomes of Renal Replacement Therapy in Patients with Severe COVID-19 Infection Requiring Mechanical Ventilation (2021) (0)
645: HOSPITAL RESOURCE USE ASSOCIATED WITH TREATMENT OF ACINETOBACTER BAUMANNII PNEUMONIA AND SEPSIS (2016) (0)
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019 (2022) (0)
Communications to the EditorEndobronchial Sarcoidosis and Hyperreactive Airways Disease (2002) (0)
Infection Plus Acute Organ Dysfunction Does Not Equal Severe Sepsis: An Examination Of Current Coding Practice (2011) (0)
Assessing the Interrater Variability of the Mortality Probability Model III (2010) (0)
COST-BENEFIT MODEL OF EMPIRIC DORIPENEM COMPARED TO IMIPENEM IN VENTILATOR-ASSOCIATED PNEUMONIA (2008) (0)
What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit? (2008) (0)
Mortality from Time of Listing for Transplantation as an Indicator of Candidate Outcomes (2004) (0)
ECONOMIC OUTCOMES FOR VENOUS THROMBOEMBOLISM MANAGEMENT BASED ON ANTICOAGULATION CHOICE (2009) (0)
1322. Complications and Hospital Resource Utilization among Patients with Bacterial Nosocomial Pneumonia in the US, 2012-2019 (2021) (0)
Healthcare-Associated Candidemia: Is It a Distinct Syndrome? (2012) (0)
PREVENTION OF VENOUS THROMBOEMBOLISM IN NEUROSURGERY: A SYSTEMATIC REVIEW (2007) (0)
Issue Information ‐ Table of Content (2022) (0)
ACINETOBACTER BUMANNII BACTEREMIA IN CRITICALLY ILL PATIENTS: EPIDEMIOLOGY, OUTCOMES, AND THE IMPACT OF OPERATION IRAQI FREEDOM (2005) (0)
The effect of warmed fresh whole blood and acute lung injury in combat casualties. (2013) (0)
Levofloxacin for Ventilator-Associated PneumoniaFREE TO VIEW (2003) (0)
Invasive Diagnostic Approaches to Ventilator-Associated Pneumonia: A Metaanalysis (2004) (0)
The authors reply. (2013) (0)
Reply to Aliberti et al and van Griensven et al (2012) (0)
Polishing the crystal ball: Improving our understanding of survival in sepsis. (2004) (0)
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial (2023) (0)
Neither APACHE II Nor CURB-65 Predict Need For Mechanical Ventilation (MV) In Patients Treated With Non-Invasive Ventilation (NIV) For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease (COPD) (2010) (0)
USING A SIMPLE MORTALITY RISK SCORE TO STRATIFY THE NEED FOR MECHANIC VENTILATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) (2008) (0)
The Burden Of C. Difficile In Patients With Severe Non-nosocomial Pneumonia (2010) (0)
1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018 (2021) (0)
EXAMINING THE BURDEN OF POTENTIALLY AVOIDABLE CHF HOSPITALIZATIONS (2023) (0)
Psychotherapy for depression in diabetes. (1999) (0)
Frequency Of Contrast Induced Nephropathy In Patients With Suspected Pulmonary Embolism Undergoing Computed Tomography Pulmonary Angiography (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Andrew f Shorr?

Andrew f Shorr is affiliated with the following schools:

Georgetown University
University of Virginia

Andrew f Shorr's Academic­Influence.com Rankings

Andrew f Shorr's Degrees

Why Is Andrew f Shorr Influential?

Andrew f Shorr's Published Works

Published Works

What Schools Are Affiliated With Andrew f Shorr?

Andrew f Shorr's AcademicInfluence.com Rankings